Category Archives: Medical Press Release

Anhydrous Dibasic Calcium Phospate Market Price, By Key Players, Trends To 2022

Global Anhydrous Dibasic Calcium Phosphate Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. Anhydrous dibasic calcium phosphate is a white, tasteless and odorless chemical compound. It is widely used in the production of medicinal and nutraceutical products.

The factors that propel the growth of the Anhydrous Dibasic Calcium Phosphate Market include increasing demand, rapid urbanization & industrialization, wide range of applications and technological innovations. Anhydrous Dibasic Calcium Phosphate Market is classified on the basis of product type, applications, distribution channel and geography.

Anhydrous Copper Sulfate Market Share,Sales, Growth Analysis By Type Forecast 2022

Global Anhydrous Copper Sulfate Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types, and its applications are increasing across the globe. Anhydrous Copper Sulfate Market is basically copper sulfate without any hydration. The formula for Anhydrous Copper Sulfate is CuSO4. This Anhydrous CuSO4 is white although hydrated one is blue in color.

Anhydrous Copper Sulfate responds directly with water to form hydrated CuSO4.5H2O.Anhydrous Copper Sulfate Industry is the one in which anhydrous form of copper sulfate occurs as mineral “hydro cyanite”. It displays a rhombic crystalline morphology. In its oxide form, the Anhydrous Copper Sulfate decomposes at temperatures above 600oC.Anhydrous Copper Sulfate Market is categorized based on product type, applications, and geography.

Asia Pacific Oxygen Therapy Market Size, Status and Forecast 2021

Asia Pacific Oxygen Therapy Devices Market was worth USD 0.34 billion in 2016 and estimated to be growing at a CAGR of 7.92%, to reach USD 0.49 billion by 2021. Oxygen therapy involves administering oxygen through an external device.

Oxygen Therapy devices are useful specially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their body. Advantages of oxygen therapy also include increased mental stamina, aversion of heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part in the management of numerous diseases. Furthermore, oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance the length and the quality of life.

Personal Mobility Devices Market Size Is Estimated To Reach $8.0 Billion By 2020: Grand View Research, Inc.

Global personal mobility devices market is expected to reach USD 8.0 billion by 2020, according to a new study by Grand View Research, Inc. Increasing geriatric population base and prevalence of target diseases are some key factors expected to drive market growth during the forecast period. Aging heightens the susceptibility of a person towards developing target diseases such as osteoporosis and rheumatoid arthritis. Therefore, a growing geriatric population base is expected to widen the patient base for manufacturers. Additionally, presence of supportive government initiatives aimed at strengthening reimbursement frameworks and growing R&D investments for new product development is expected to propel market growth over the next six years.

3D Bioprinting Market Hits $1.82 Billion By 2022: Grand View Research, Inc.

Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD) which demands kidney transplantation is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation.

Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities.

Commercial Pharmaceutical Analytics Market by Key Players, Growth, Regions and Forecast to 2027

All around the market for Commercial Pharmaceutical Analytics is expanding quickly. The central point that drives the development of Commercial Pharmaceutical Analytics is developing selection of new advancements and systematic devices, expanding use of scientific apparatuses to streamline the business procedure, developing pharmaceutical industry and others. The Commercial Pharmaceutical Analytics Market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. Globally the market for commercial pharmaceutical analytics market is expected to grow at the rate of about 20.0% from 2016 to 2027.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/828 .

Diphtheria Treatment Market-Outlook, Regulatory Bodies, Trends, Industry Insights & Forecast

The market for diphtheria treatment is expected to reach $ 5 billion by the end of 2023, this market is projected to be growing at a CAGR of ~ 3.2 % during 2017-2023.

Diphtheria is a convincing sickness caused by the bacterium Corynebacterium diphtheria causing authentic sore throat and fever inciting narrowing of the air areas and crying hack. Diphtheria may in like way affect the skin, eyes, or private parts and may cause myocarditis, exhausting and kidney issues. The World Diphtheria Treatment Market is making at a move back rate because of high adequacy and ability of the neutralizing specialist, falling gainfulness of immunization produce, appearances related with vaccinations, for example, sort a sheltered response and sensitivities, abnormality in the possibility of antibodies. Money related obstructions, for example, falling rates of benefit and the resultant exit of various players from immunizer convey will affect the future progression of vaccinations.

Genu Recurvatum Market – Key Players, Growth Rate and Forecasts to 2023

Genu Recurvatum is a rare orthopedic complication in which the hyperextension of the knee is greater than five degrees. It is also known as back knee or knee hyperextension. It occurs more frequently in females than it does in males, and is commonly, identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). Global Genu Recurvatum Market is growing rapidly. This condition causes stress in the posterior knee structures which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies.  It is estimated that genu recurvatum market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.

Desmoid Tumors Market – Key Players, Growth Rate and Forecasts to 2023

Desmoid tumors are also known as desmoid fibromatosis. These benign growths occur very rarely in the general population. Desmoid tumor usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. The term desmoid was derived from the Greek word desmos, which means tendonlike. Desmoid tumors appear as well-differentiated, and firm overgrowths of fibrous tissue. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors. The Global Desmoid Tumors Market is Growing Rapidly by Forecasted Peroid. It is estimated that desmoid tumors market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.